Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Crager

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
European Heart Journal|September 24, 2005
Effects of ranolazine on exercise tolerance and HbA1c in patients with chronic angina and diabetesAdam D Timmis, Bernard R Chaitman, Michael Crager
The American Journal of Geriatric Cardiology|July 10, 2007
Safety and efficacy of extended-release ranolazine in patients aged 70 years or older with chronic stable angina pectorisMichael W Rich, Michael Crager, Charles R McKay
Breast Cancer Research : BCR|November 2, 2022
Population-based estimate for the correlation of the Oncotype Dx Breast Recurrence Score® result and Ki-67 IHC MIB-1 pharmDx in HR+, HER2-, node-positive early breast cancerMichael Crager, Sameera R Wijayawardana, Aaron M Gruver, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2011
Risk of recurrence and chemotherapy benefit for patients with node-negative, estrogen receptor-positive breast cancer: recurrence score alone and integrated with pathologic and clinical factorsGong Tang, Jack Cuzick, Joseph P Costantino, et al.
NPJ Breast Cancer|November 21, 2018
21-Gene assay as predictor of chemotherapy benefit in HER2-negative breast cancerCharles E Geyer, Gong Tang, Eleftherios P Mamounas, et al.
Plos One|July 19, 2012
Whole transcriptome RNA-Seq analysis of breast cancer recurrence risk using formalin-fixed paraffin-embedded tumor tissueDominick Sinicropi, Kunbin Qu, Francois Collin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 5, 2020
17-Gene Genomic Prostate Score Test Results in the Canary Prostate Active Surveillance Study (PASS) CohortDaniel W Lin, Yingye Zheng, Jesse K McKenney, et al.
NEJM Evidence|July 23, 2024
Clinical and Genomic Risk for Late Breast Cancer Recurrence and SurvivalJoseph A Sparano, Michael Crager, Robert J Gray, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
European Heart Journal|September 24, 2005
Effects of ranolazine on exercise tolerance and HbA1c in patients with chronic angina and diabetesAdam D Timmis, Bernard R Chaitman, Michael Crager
The American Journal of Geriatric Cardiology|July 10, 2007
Safety and efficacy of extended-release ranolazine in patients aged 70 years or older with chronic stable angina pectorisMichael W Rich, Michael Crager, Charles R McKay
Breast Cancer Research : BCR|November 2, 2022
Population-based estimate for the correlation of the Oncotype Dx Breast Recurrence Score® result and Ki-67 IHC MIB-1 pharmDx in HR+, HER2-, node-positive early breast cancerMichael Crager, Sameera R Wijayawardana, Aaron M Gruver, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2011
Risk of recurrence and chemotherapy benefit for patients with node-negative, estrogen receptor-positive breast cancer: recurrence score alone and integrated with pathologic and clinical factorsGong Tang, Jack Cuzick, Joseph P Costantino, et al.
NPJ Breast Cancer|November 21, 2018
21-Gene assay as predictor of chemotherapy benefit in HER2-negative breast cancerCharles E Geyer, Gong Tang, Eleftherios P Mamounas, et al.
Plos One|July 19, 2012
Whole transcriptome RNA-Seq analysis of breast cancer recurrence risk using formalin-fixed paraffin-embedded tumor tissueDominick Sinicropi, Kunbin Qu, Francois Collin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 5, 2020
17-Gene Genomic Prostate Score Test Results in the Canary Prostate Active Surveillance Study (PASS) CohortDaniel W Lin, Yingye Zheng, Jesse K McKenney, et al.
NEJM Evidence|July 23, 2024
Clinical and Genomic Risk for Late Breast Cancer Recurrence and SurvivalJoseph A Sparano, Michael Crager, Robert J Gray, et al.
Pageof 1